SBT-0704: A Covid-19 Therapeutic Drug Candidate

New York/No City
  • Price: $0
  • Gross Income: $0
  • Cash Flow: $0
  • FFE: $0
  • Inventory: $0
  • Real Estate Value: $0
  • Source Data:
About the Business
  • Listing ID: #10457
  • Year Established: 0
  • Financing: 0
  • Training: 0
  • Facilities:
  • Competition:
  • Growth:
  • Employees:

Property Descriptions

Seeking partnerships of a pharmaceutical company to advance clinical testing, or Sale of an antiviral drug for COVID-19: the company is currently developing potential antiviral compounds for the primary drug candidate, SBT-0704. The drug is designed both for prophylactic and antiviral use and is intended to be administered via a single-use inhaler. SBT-0704 brings the power to fight COVID directly to the user, without visiting a clinic for administration and intended for use in any setting. The company has decided to review offers from interested parties to acquire the relevant intellectual property and develop it either on its own or via a strategic partnership. 10457

The information in this listing has been provided by the business seller or representative stated above. The Business Broker Journal has no stake in the sale of this business, has not verified the accuracy, completeness, and assumes no responsibility for this advertisement. Read our Terms and Conditions for more information.

Business Listed By

1475 S Bascom Ave, Suite 113, California, Campbell